Search

everythinglearnresearchcommunity

for

Search:↓

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Annurca apple extract may protect mouse hair from damage by chemotherapy and could help treat hair loss without promoting cancer growth.

Madarosis (eyebrow and eyelash loss) significantly affects quality of life for breast cancer patients on taxane-based chemotherapy.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

Low-intensity ultrasound may protect hair follicles from damage caused by a common chemotherapy drug.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

Scalp cooling is an effective and safe way to prevent hair loss from chemotherapy, with manageable side effects and low risk of scalp cancer.

The document concluded that there were no effective ways to prevent hair loss from chemotherapy but treatments were being explored.

Some patients' hair grew back black and white after chemotherapy.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Topical minoxidil may help regrow hair after permanent hair loss from chemotherapy.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Scalp cooling is an effective way to prevent hair loss from chemotherapy.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Melatonin may protect hair follicle stem cells from damage caused by chemotherapy.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.